FORMULARY WATCH

OPIOID DRUGS

TODAY'S HEADLINES

How FDA aims to support generic opioids

FDA just issued a draft guidance to support manufacturers in developing generic versions of approved opioids with abuse-deterrent formulations. Read more

New anthrax injection available

FDA recently approved obiltoxaximab injection (Anthim, Elusys Therapeutics) to treat inhalational anthrax. Read more

CONTINUING PHARMACY EDUCATION

Part 2: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose

This month's CE activity is open for pharmacists and pharmacy technicians. "Part II: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

Walgreens, OptumRx form pharmacy partnership

The new joint venture between Walgreens Boots Alliance and OptumRx may signal that Walgreens is not looking to buy another PBM. Inside the partnership

March 30, 2016

FDA requires warning on opioids

Treatment for inhalational anthrax approved

Click to contact the editorial team. Click to contact the sales team.

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us